Medifast (MED) Net Margin (2010 - 2026)

Medifast's Net Margin history runs 17 years deep, the most recent figure standing at 2.82% for Q1 2026.

• Quarterly Net Margin fell 215.0% year-over-year to 2.82% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.78% (down 450.0% YoY) and the FY2025 annual result came in at 4.83%, down 518.0% from the prior year.
• Net Margin was 2.82% for Q1 2026 at Medifast, up from 24.08% in the prior quarter.
• Across five years, Net Margin topped out at 11.45% in Q1 2023 and bottomed at 24.08% in Q4 2025.
• A 5-year average of 2.59% and a median of 3.16% in 2023 frame the typical range for Net Margin.
• Peak annual rise in Net Margin reached 718 bps in 2025, while the deepest fall reached 2475 bps in 2025.
• Medifast's Net Margin stood at 7.86% in 2022, then plunged by 60 bps to 3.16% in 2023, then tumbled by 79 bps to 0.67% in 2024, then tumbled by 3677 bps to 24.08% in 2025, then jumped by 88 bps to 2.82% in 2026.
• Business Quant data shows MED's Net Margin at 2.82% in Q1 2026, 24.08% in Q4 2025, and 2.52% in Q3 2025.